TrialClinical cancer research : an official journal of the American Association for Cancer Research2011

A phase I clinical-pharmacodynamic study of the farnesyltransferase inhibitor tipifarnib in combination with the proteasome inhibitor bortezomib in advanced acute leukemias.

Jeffrey E Lancet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.